Purinergic signaling comprises one key pathway in modulating bladder smooth muscle (BSM) contractility, disorders of which become highly prevalent with aging. ADP was first observed to modulate BSM contractility >40 yr ago, yet the underlying molecular mechanism still remains unclear. Here, we demonstrate, using myography, that ADP and ADPS dose-dependently induce mouse BSM contraction, and ADP-induced BSM contraction is blocked by a selective P2Y 12 receptor (P2Y 12 R) antagonist, PSB 0739 (25 M), but is unaffected by P2Y 1 and P2Y 13 receptor antagonists. Lower urinary tract symptoms (LUTS), including bladder overactivity, urinary urgency and frequency, urinary incontinence, and bladder pain, afflict millions of people and severely compromise quality of life and independence. A recent study reported that LUTS were highly prevalent among men and women aged Ͼ40 yr, with Ͼ70% experiencing some symptoms (1). The etiology of LUTS is extremely poorly understood, and treatment options are few and of limited efficacy.Bladder smooth muscle (BSM) plays an essential role during urinary filling and voiding, with highly coordinated phases of relaxation and contraction. Consequently, myogenic disorders are frequently involved in LUTS, as may be seen with the development of significant noncholinergic and non-P2X 1 receptor-mediated contraction in diabetic bladder dysfunction (2), yet knowledge of the underlying mechanisms remains poorly understood (3).BSM contractility is, in part, regulated by purinergic signaling. Extracellular purines like ATP and UTP can be released either as neurotransmitters at neuromuscular junctions or from somatic cells in response to environmental stress, and they bind to P2X (1-7) and P2Y (1,2,4,6,(11)(12)(13)(14) receptors to elicit downstream signaling. ATP/UTP can be further sequentially converted into ADP/UDP and ultimately to adenosine by ectonucleotidases to activate P2Y receptors and adenosine receptors (P1) correspondingly. Thus, ectonucleotidases temporally and spatially regulate the availability of purines to activate P1 and P2 receptors (4).The functional significance of purinergic signaling in regulating bladder and other organs had been shown Ͼ40 yr ago, in experiments with neuronal release or exogenously applied purines causing smooth muscle